Clinical Application and Study of Ultrasound-Guided Chemoablation of Uterine Leiomyoma

CAI Chenkai, LI Ronghua, XIU Yanghao, CHEN Jinhua

Guide of China Medicine ›› 2025, Vol. 23 ›› Issue (12) : 105-107.

PDF(569 KB)
PDF(569 KB)
Guide of China Medicine ›› 2025, Vol. 23 ›› Issue (12) : 105-107. DOI: 10.15912/j.issn.1671-8194.2025.12.029
Application Research

Clinical Application and Study of Ultrasound-Guided Chemoablation of Uterine Leiomyoma

  • CAI Chenkai*, LI Ronghua, XIU Yanghao, CHEN Jinhua
Author information +

Abstract

Objective To investigate the clinical effect of ultrasound-guided chemical ablation of uterine fibroids. Methods Selecting 34 patients with uterine fibroids from Longyan People's Hospital from July 2022 to March 2024 as the subjects, 17 cases in each group. The control group was treated with microwave, and the observation group was treated with ultrasound-guided chemical ablation of uterine fibroids. The effects of the two groups were evaluated after 1 month of treatment, and the patients were followed up for 6 months. The clinical effect (volume reduction rate), hemoglobin, menstrual volume score, estrogen and progesterone, treatment cost and long-term response were compared between the two groups. Results The effective rate of observation group was higher than that of control group (P<0.05). The hemoglobin of observation group was higher than that of control group after intervention (P<0.05). Menstrual volume score and treatment cost were lower than control group, and E2, FSH and LH in observation group were lower than control group (P<0.05).Conclusions Ultrasound-guided chemical ablation of uterine fibroids has a good effect in patients with uterine fibroids, which can improve the volume reduction rate of patients, reduce the score of menstrual volume, help improve the level of estrogen and progesterone, reduce the treatment cost.

Key words

Ultrasonic guidance / Uterine fibroids / Chemical ablation / Therapeutic effect / Inflammatory factors / Estrogen / Therapeutic safety

Cite this article

Download Citations
CAI Chenkai, LI Ronghua, XIU Yanghao, CHEN Jinhua. Clinical Application and Study of Ultrasound-Guided Chemoablation of Uterine Leiomyoma[J]. Guide of China Medicine. 2025, 23(12): 105-107 https://doi.org/10.15912/j.issn.1671-8194.2025.12.029

References

[1] 高晶晶,徐俊,陈立萍. 超声下聚桂醇化学消融联合米非司酮治疗子宫肌瘤的临床价值[J]. 中外医学研究,2024,22(19):108-111.
[2] 詹小霜,王迎. 腹腔镜联合超声引导经皮微波消融治疗子宫肌瘤疗效的研究[J]. 影像科学与光化学,2022,40(2):392-396.
[3] Dai Y,Chen H,Yu J,et al.Global and regional trends in the incidence and prevalence of uterine fibroids and attributable risk factors at the national level from 2010 to 2019:A worldwide database study[J]. Chin Med J,2024,137(21):2583-2589.
[4] 刘欣,汪伟,唐杰,等. 子宫肌瘤聚焦超声消融手术与子宫肌瘤剔除术的远期临床疗效比较[J]. 中华妇产科杂志,2022,57(4):244-252.
[5] 秦海英,张燕妮,王珊珊,等. 热消融子宫肌瘤对子宫肌瘤患者术后子宫内膜容受性和性激素水平的影响[J]. 临床和实验医学杂志,2023,22(19):2065-2069.
[6] 中国医师协会妇产科医师分会妇科肿瘤专业委员会(学组). 良性子宫疾病子宫切除术手术路径的中国专家共识(2021年版)[J]. 中国实用妇科与产科杂志,2021,37(8):821-825.
[7] Chen R,You J.Comparison of hysterectomy and uterine artery embolization in the treatment of symptomatic uterine fibroids:A protocol for systematic review and meta-analysis[J]. Medicine,2022,101(52):e32440.
[8] 罗锦文,何月明,张婷,等. 基于MR-T2WI纹理分析在预测子宫肌瘤高强度聚焦超声消融术后疗效的价值[J]. 中国医学计算机成像杂志,2024,30(2):250-258.
[9] 白奇峰,李琴芳,寿炎明. 超声血流成像评价子宫肌瘤微波消融术前肌瘤血供状态的价值[J]. 中国妇幼保健,2022,37(10):1916-1919.
[10] 董欣,庞晓卿,任鹏,等. 子宫肌瘤患者行高强度聚焦超声消融术对妊娠的影响[J].武警医学,2024,35(2):157-160.
[11] 高晶晶,徐俊,陈立萍.超声下聚桂醇化学消融联合米非司酮治疗子宫肌瘤的临床价值[J].中外医学研究,2024,22(19):108-111.
PDF(569 KB)

Accesses

Citation

Detail

Sections
Recommended

/